Associations of polymorphisms in adiponectin and leptin genes with men's longevity

Aging Male

Volumn 13, Issue 3, 2010, Pages 188-193

  Khabour, Omar F ^a   Mesmar, Fahmi S ^a   Alatoum, Mohammad A ^a   Gharaibeh, Mohammad Y ^a   Alzoubi, Karem H ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Adiponectin; Jordan; leptin; longevity; SNP

Indexed keywords

ADIPONECTIN; LEPTIN;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; JORDAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; JORDAN; LEPTIN; LONGEVITY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; YOUNG ADULT;

EID: 77955912452     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685531003657800     Document Type: Article

References (40)

1. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 1999;892:146-154.
2. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006;94:1221-1225.
3. Mao X, Hong JY, Dong LQ. The adiponectin signaling pathway as a novel pharmacological target. Mini Rev Med Chem 2006;6:1331-1340.
4. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004;53:2473-2478. (Pubitemid 39145606)
5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89.
6. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004;43:1318-1323.
7. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. Serum adiponectin is associated with high-density lipoprotein cholesterol, triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism 2004;53:589-593.
8. Goyenechea E, Collins LJ, Parra D, Abete I, Crujeiras AB, O'Dell SD, Martinez JA. The-11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm Metab Res 2009;41:55-61.
9. Huang H, Tada Iida K, Murakami H, Saito Y, Otsuki T, Iemitsu M, Maeda S, Sone H, Kuno S, Ajisaka R. Influence of adiponectin gene polymorphism SNP276 (G/T) on adiponectin in response to exercise training. Endocr J 2007;54:879-886.
10. Li LL, Kang XL, Ran XJ, Wang Y, Wang CH, Huang L, Ren J, Luo X, Mao XM. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol 2007;34: 1287-1290.
11. Le Stunff C, Le Bihan C, Schork NJ, Bougneres P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000;49:2196-2200.
12. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34:355-359.
13. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006;6:38.
14. Ribeiro R, Araujo AP, Coelho A, Catarino R, Pinto D, Araujo A, Calcada C, Lopes C, Medeiros R. A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 2006;42:1188-1193.
15. Ribeiro R, Vasconcelos A, Costa S, Pinto D, Morais A, Oliveira J, Lobo F, Lopes C, Medeiros R. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004;59:268-274.
16. Bik W, Baranowska B. Adiponectin-a predictor of higher mortality in cardiovascular disease or a factor contributing to longer life? Neuro Endocrinol Lett 2009;30:180-184.
17. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, Scherer PE, Rincon M, Siegel G, Katz M, Lipton RB, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008;63:447-453.
18. Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, Jeste DV. Successful aging: from phenotype to genotype. Biol Psychiatry 2007;62:282-293.
19. Khoury SA, Massad D, Fardous T. Mortality and causes of death in Jordan 1995-1996: assessment by verbal autopsy. Bull World Health Organ 1999;77:641-650.
20. Jordan in Numbers. [Internet]. Amman, Jordan, Department of statistics 2007 [cited 2010, January 11]. Available from: http://www.dos.gov.jo
21. Li Z, Peng X, Wu Y, Xia Y, Liu X, Zhang Q. The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes. Diabetes Obes Metab 2008;10:794-802.
22. Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001;31:2357-2361.
23. Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J. Polymorphisms in cytokine genes influence longterm survival differently in elderly male and female patients. J Intern Med 2007;262:215-223.
24. Franceschi C, Motta L, Valensin S, Rapisarda R, Franzone A, Berardelli M, Motta M, Monti D, Bonafe M, Ferrucci L, et al. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) 2000;12:77-84.
25. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Franceschi C, Caruso C. Genderspecific association between-1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002;3:30-33.
26. Bacci S, Menzaghi C, Ercolino T,Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A, et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004;27:2015-2020.
27. Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin: adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intimamedia thickness. Diabetologia 2005;48:2684-2686.
28. Mori I, Ishizuka T, Morita H, Matsumoto M, Uno Y, Kajita K, Ikeda T, Fujioka K, Matsubara K. Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circ J 2008;72: 1680-1684.
29. Menzaghi C, Ercolino T, Salvemini L, Coco A, Kim SH, Fini G, Doria A, Trischitta V. Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 2004;19:170-174.
30. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D, Doria A, Hu FB. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005;54:1607-1610.
31. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M, Fallarino M, Sorropago G, et al. The adiponectin gene SNP+276G4T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age 5or=50 years). J Mol Med 2005;83:711-719.
32. Szopa M, Malczewska-Malec M, Wilk B, Skupien J, Wolkow P, Malecki MT, Sieradzki J. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 2009;46:317-322.
33. Ben Ali S, Kallel A, Ftouhi B, Sediri Y, Feki M, Slimane H, Jemaa R, Kaabachi N. Association of G-2548A LEP polymorphism with plasma leptin levels in Tunisian obese patients. Clin Biochem 2009;42:584-588.
34. Barbieri M, Bonafe M, Rizzo MR, Ragno E, Olivieri F, Marchegiani F, Franceschi C, Paolisso G. Gender specific association of genetic variation in peroxisome proliferatoractivated receptor (PPAR)gamma-2 with longevity. Exp Gerontol 2004;39:1095-1100.
35. De Luca M, Rose G, Bonafe M, Garasto S, Greco V, Weir BS, Franceschi C, De Benedictis G. Sex-specific longevity associations defined by Tyrosine Hydroxylase-Insulin-Insulin Growth Factor 2 haplotypes on the 11p15.5 chromosomal region. Exp Gerontol 2001;36:1663-1671.
36. Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, Paykel ES, Rubinsztein DC. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997;129:177-183.
37. Lio D, Balistreri CR, Colonna-Romano G, Motta M, Franceschi C, Malaguarnera M, Candore G, Caruso C. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population. Genes Immun 2002;3:20-24.
38. May RC. Gender, immunity and the regulation of longevity. Bioessays 2007;29:795-802.
39. Kim SH, Kang ES, Hur KY, Lee HJ, Han SJ, Kwak JY, Nam CM, Ahn CW, Cha BS, Lee HC. Adiponectin gene polymorphism 45T4G is associated with carotid artery plaques in patients with type 2 diabetes mellitus. Metabolism 2008;57: 274-279.
40. Mohammadzadeh G, Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Invest 2009:69:764-771.